Stage IIA2 Cervical Cancer AJCC v8
specificStage IIA2 includes: T2a2, N0, M0. Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion. T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)
12
Centers
1
Active Trials
—
Cancer Funding
Top Centers for Stage IIA2 Cervical Cancer AJCC v8(12)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive High-Volume Research Center | 74.8 |
| 2 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 52.3 |
| 3 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 52.3 |
| 4 | NCI Comprehensive | 52.3 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 52.3 |
| 6 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 52.3 |
| 7 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive | 52.3 |
| 8 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive | 52.3 |
| 9 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 52.3 |
| 10 | Cleveland Clinic Cancer CenterCleveland, OH | 52.3 |
| 11 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive | 52.3 |
| 12 | Georgia Cancer Center, Augusta UniversityAugusta, GA | 52.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →